These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9386137)

  • 1. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension.
    Friedman R; Mears JG; Barst RJ
    Circulation; 1997 Nov; 96(9):2782-4. PubMed ID: 9386137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
    Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilator therapy for primary pulmonary hypertension in children.
    Barst RJ; Maislin G; Fishman AP
    Circulation; 1999 Mar; 99(9):1197-208. PubMed ID: 10069788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy.
    Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Satoh T; Nakanishi N
    Circulation; 2000 Nov; 102(22):2720-5. PubMed ID: 11094038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
    Nakayama T; Ishikita T; Matsuura H; Saji T
    J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The place of prostacyclin in the clinical management of primary pulmonary hypertension.
    Higenbottam T
    Am Rev Respir Dis; 1987 Sep; 136(3):782-5. PubMed ID: 3307576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension.
    Raffy O; Azarian R; Brenot F; Parent F; Sitbon O; Petitpretz P; Hervé P; Duroux P; Dinh-Xuan AT; Simonneau G
    Circulation; 1996 Feb; 93(3):484-8. PubMed ID: 8565165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of PGI2 analogue on vascular endothelial function and platelet aggregation in patients with NIDDM.
    Nishimura M; Nozaki O; Nakano H; Tsuchida H; Yamada K
    J Diabetes Complications; 1995; 9(4):330-3. PubMed ID: 8573759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the treatment of pediatric pulmonary artery hypertension.
    Barst RJ
    Pediatr Clin North Am; 1999 Apr; 46(2):331-45. PubMed ID: 10218078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.
    Sitbon O; Brenot F; Denjean A; Bergeron A; Parent F; Azarian R; Herve P; Raffestin B; Simonneau G
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):384-9. PubMed ID: 7842196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension.
    Saji T; Ozawa Y; Ishikita T; Matsuura H; Matsuo N
    Am J Cardiol; 1996 Jul; 78(2):244-7. PubMed ID: 8712155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets, von Willebrand factor, and prostaglandin I2.
    Moake JL; Tang SS; Olson JD; Troll JH; Cimo PL; Davies PJ
    Am J Physiol; 1981 Jul; 241(1):H54-9. PubMed ID: 6787937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostacyclin on pulmonary vascular response to thrombin in awake sheep.
    Perlman MB; Lo SK; Malik AB
    J Appl Physiol (1985); 1986 Feb; 60(2):546-53. PubMed ID: 3512510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.
    Montalescot G; Drobinski G; Meurin P; Maclouf J; Sotirov I; Philippe F; Choussat R; Morin E; Thomas D
    Am J Cardiol; 1998 Sep; 82(6):749-55. PubMed ID: 9761085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.
    Rosenzweig EB; Kerstein D; Barst RJ
    Circulation; 1999 Apr; 99(14):1858-65. PubMed ID: 10199883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.